Severe Vasculitis Yields to Rituximab MedPage Today One small study documented that rituximab was very effective and well-tolerated therapy for HCV-associated cryoglobulinemic vasculitis in patients in whom antiviral therapy had failed to induce remission. In a second, larger study, ... |
